These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9843996)

  • 1. The akt kinase: molecular determinants of oncogenicity.
    Aoki M; Batista O; Bellacosa A; Tsichlis P; Vogt PK
    Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14950-5. PubMed ID: 9843996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase.
    Chang HW; Aoki M; Fruman D; Auger KR; Bellacosa A; Tsichlis PN; Cantley LC; Roberts TM; Vogt PK
    Science; 1997 Jun; 276(5320):1848-50. PubMed ID: 9188528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt.
    Aoki M; Blazek E; Vogt PK
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):136-41. PubMed ID: 11134523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation.
    Bader AG; Vogt PK
    Mol Cell Biol; 2005 Mar; 25(6):2095-106. PubMed ID: 15743808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins.
    Aoki M; Jiang H; Vogt PK
    Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13613-7. PubMed ID: 15342912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The catalytic subunit of phosphoinositide 3-kinase: requirements for oncogenicity.
    Aoki M; Schetter C; Himly M; Batista O; Chang HW; Vogt PK
    J Biol Chem; 2000 Mar; 275(9):6267-75. PubMed ID: 10692423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells.
    Jiang BH; Zheng JZ; Aoki M; Vogt PK
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1749-53. PubMed ID: 10677529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway.
    Bader AG; Felts KA; Jiang N; Chang HW; Vogt PK
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12384-9. PubMed ID: 14530393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
    Kim DW; Hwang JH; Suh JM; Kim H; Song JH; Hwang ES; Hwang IY; Park KC; Chung HK; Kim JM; Park J; Hemmings BA; Shong M
    Mol Endocrinol; 2003 Jul; 17(7):1382-94. PubMed ID: 12738763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
    Kang S; Bader AG; Vogt PK
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):802-7. PubMed ID: 15647370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic transformation induced by membrane-targeted Akt2 and Akt3.
    Mende I; Malstrom S; Tsichlis PN; Vogt PK; Aoki M
    Oncogene; 2001 Jul; 20(32):4419-23. PubMed ID: 11466625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy.
    Sundaresan NR; Pillai VB; Wolfgeher D; Samant S; Vasudevan P; Parekh V; Raghuraman H; Cunningham JM; Gupta M; Gupta MP
    Sci Signal; 2011 Jul; 4(182):ra46. PubMed ID: 21775285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.
    Skorski T; Bellacosa A; Nieborowska-Skorska M; Majewski M; Martinez R; Choi JK; Trotta R; Wlodarski P; Perrotti D; Chan TO; Wasik MA; Tsichlis PN; Calabretta B
    EMBO J; 1997 Oct; 16(20):6151-61. PubMed ID: 9321394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic signaling of class I PI3K isoforms.
    Denley A; Kang S; Karst U; Vogt PK
    Oncogene; 2008 Apr; 27(18):2561-74. PubMed ID: 17998941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation.
    Akagi T; Shishido T; Murata K; Hanafusa H
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7290-5. PubMed ID: 10852971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targeting: PI3 kinase pathway.
    Dancey JE
    Ann Oncol; 2004; 15 Suppl 4():iv233-9. PubMed ID: 15477314
    [No Abstract]   [Full Text] [Related]  

  • 17. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential.
    Ahmed NN; Franke TF; Bellacosa A; Datta K; Gonzalez-Portal ME; Taguchi T; Testa JR; Tsichlis PN
    Oncogene; 1993 Jul; 8(7):1957-63. PubMed ID: 8510938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy.
    Tan J; Li Z; Lee PL; Guan P; Aau MY; Lee ST; Feng M; Lim CZ; Lee EY; Wee ZN; Lim YC; Karuturi RK; Yu Q
    Cancer Discov; 2013 Oct; 3(10):1156-71. PubMed ID: 23887393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin inhibits Akt-mediated oncogenic transformation and tumor growth.
    Liu X; Powlas J; Shi Y; Oleksijew AX; Shoemaker AR; De Jong R; Oltersdorf T; Giranda VL; Luo Y
    Anticancer Res; 2004; 24(5A):2697-704. PubMed ID: 15517874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway.
    Khwaja A; Rodriguez-Viciana P; Wennström S; Warne PH; Downward J
    EMBO J; 1997 May; 16(10):2783-93. PubMed ID: 9184223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.